血浆置换在危重病中的作用。
The role of plasmapheresis in critical illness.
机构信息
Section of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Houston, TX 77030, USA.
出版信息
Crit Care Clin. 2012 Jul;28(3):453-68, vii. doi: 10.1016/j.ccc.2012.04.009.
Abstract
In this article, the authors review the current recommendations from the American Society for Apheresis regarding the use of plasmapheresis in many of the diseases that intensivists commonly encounter in critically ill patients. Recent experience indicates that therapeutic plasma exchange may be useful in a wide spectrum of illnesses characterized by microvascular thrombosis, the presence of autoantibodies, immune activation with dysregulation of immune response, and some infections.
摘要
在这篇文章中，作者回顾了美国血浆分离协会目前关于在危重病患者中常见的许多疾病中使用血浆置换的建议。最近的经验表明，治疗性血浆置换可能对广泛的疾病有用，这些疾病的特点是微血管血栓形成、自身抗体存在、免疫激活伴免疫反应失调，以及一些感染。
相似文献
1
The role of plasmapheresis in critical illness.血浆置换在危重病中的作用。
Crit Care Clin. 2012 Jul;28(3):453-68, vii. doi: 10.1016/j.ccc.2012.04.009.
2
Therapeutic Plasma Exchange in the Critically Ill Patient: Technology and Indications.危重症患者的治疗性血浆置换：技术与适应证。
Adv Chronic Kidney Dis. 2021 Jan;28(1):59-73. doi: 10.1053/j.ackd.2021.03.005.
3
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.).《成人危重症患者营养支持治疗的提供与评估指南：危重症医学会（SCCM）和美国肠外肠内营养学会（A.S.P.E.N.）》
JPEN J Parenter Enteral Nutr. 2009 May-Jun;33(3):277-316. doi: 10.1177/0148607109335234.
4
Plasmapheresis in the critically ill patient.重症患者的血浆置换
Kidney Int Suppl. 1998 May;66:S178-81.
5
[Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): introduction and methodology].[危重症患者特殊营养与代谢支持指南。更新版。西班牙重症监护医学与冠心病监护病房学会 - 西班牙肠外与肠内营养学会（SEMICYUC - SENPE）共识：引言与方法]
Med Intensiva. 2011 Nov;35 Suppl 1:1-6. doi: 10.1016/S0210-5691(11)70001-8.
6
Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications.危重症患者的细胞单采和血浆置换疗法：第二部分：临床指征与应用
J Intensive Care Med. 2005 Mar-Apr;20(2):88-103. doi: 10.1177/0885066604273479.
7
Society of Critical Care Medicine and American Society of Health-System Pharmacists Guideline for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults: Erratum.
Crit Care Med. 2024 Oct 1;52(10):e535. doi: 10.1097/CCM.0000000000006392. Epub 2024 Sep 16.
8
Evidence-based nutrition guidelines for critically ill adults.危重症成年患者的循证营养指南
JAMA. 2009 Apr 15;301(15):1543; author reply 1543-4. doi: 10.1001/jama.2009.493.
9
Evidence-Based Medicine and the American Thoracic Society Clinical Practice Guidelines.循证医学与美国胸科学会临床实践指南。
JAMA Intern Med. 2019 Apr 1;179(4):584-586. doi: 10.1001/jamainternmed.2018.7461.
10
Selective Plasma Exchange for Critically Ill Patients Accompanied With Thrombocytopenia.伴有血小板减少症的危重症患者的选择性血浆置换
Ther Apher Dial. 2016 Aug;20(4):339-41. doi: 10.1111/1744-9987.12464.
引用本文的文献
1
Immunomodulation in Pediatric Sepsis: A Narrative Review.儿童脓毒症中的免疫调节：一篇叙述性综述
J Clin Med. 2025 Apr 25;14(9):2983. doi: 10.3390/jcm14092983.
2
Plasma Exchange in Pediatric Neurology Patients: A Single-Center Experience.小儿神经病学患者的血浆置换：单中心经验
Cureus. 2024 Jan 21;16(1):e52691. doi: 10.7759/cureus.52691. eCollection 2024 Jan.
3
Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis.血浆及经血浆处理的足细胞的蛋白质组学：在局灶节段性肾小球硬化中的应用
Int J Mol Sci. 2023 Jul 28;24(15):12124. doi: 10.3390/ijms241512124.
4
Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management.药物性血栓性微血管病：致病药物、病理生理学及管理的最新综述
Front Pharmacol. 2023 Jan 9;13:1088031. doi: 10.3389/fphar.2022.1088031. eCollection 2022.
5
Apheresis and COVID-19 in intensive care unit (ICU).血浆治疗与重症监护病房（ICU）中的 COVID-19。
Transfus Apher Sci. 2022 Dec;61(6):103593. doi: 10.1016/j.transci.2022.103593. Epub 2022 Nov 1.
6
A possibilistic-robust-fuzzy programming model for designing a game theory based blood supply chain network.一种基于博弈论的血液供应链网络设计的可能性-鲁棒-模糊规划模型。
Appl Math Model. 2022 Dec;112:282-303. doi: 10.1016/j.apm.2022.08.003. Epub 2022 Aug 5.
7
Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer's disease by whole blood exchange.通过全血置换预防和治疗阿尔茨海默病模型中的淀粉样蛋白沉积和行为障碍。
Mol Psychiatry. 2022 Oct;27(10):4285-4296. doi: 10.1038/s41380-022-01679-4. Epub 2022 Jul 15.
8
Plasmapheresis: Is it a potential alternative treatment for chronic urticaria?血浆置换：它是慢性荨麻疹的一种潜在替代治疗方法吗？
Open Med (Wars). 2021 Dec 23;17(1):113-118. doi: 10.1515/med-2021-0399. eCollection 2022.
9
Therapeutic Plasma Exchange in Pediatric Intensive Care Unit: A Single-center Experience.儿科重症监护病房中的治疗性血浆置换：单中心经验
Indian J Crit Care Med. 2021 Oct;25(10):1189-1192. doi: 10.5005/jp-journals-10071-23985.
10
Therapeutic plasma exchange in children with acute liver failure (ALF): is it time for incorporation into the ALF armamentarium?儿童急性肝衰竭（ALF）的治疗性血浆置换：是否是时候将其纳入 ALF 的治疗方法中？
Pediatr Nephrol. 2022 Aug;37(8):1775-1788. doi: 10.1007/s00467-021-05289-0. Epub 2021 Oct 14.
本文引用的文献
1
Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?患有继发性噬血细胞性淋巴组织细胞增生症/脓毒症/多器官功能障碍综合征/巨噬细胞活化综合征的危重症儿童的高铁蛋白血症：如何治疗？
Crit Care. 2012 Dec 12;16(2):R52. doi: 10.1186/cc11256.
2
Acute liver failure.急性肝衰竭。
Semin Respir Crit Care Med. 2012 Feb;33(1):36-45. doi: 10.1055/s-0032-1301733. Epub 2012 Mar 23.
3
GABAergic neurosteroids: the "endogenous benzodiazepines" of acute liver failure.GABA 能神经甾体：急性肝衰竭的“内源性苯二氮䓬类”。
Neurochem Int. 2012 Jun;60(7):707-14. doi: 10.1016/j.neuint.2011.10.003. Epub 2011 Oct 21.
4
How I treat hemophagocytic lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症的治疗方法。
Blood. 2011 Oct 13;118(15):4041-52. doi: 10.1182/blood-2011-03-278127. Epub 2011 Aug 9.
5
Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults.噬血细胞性淋巴组织细胞增生症：成人全身炎症反应综合征、严重脓毒症和感染性休克的潜在被忽视的关联。
Chest. 2011 Oct;140(4):933-938. doi: 10.1378/chest.11-0619. Epub 2011 Jul 7.
6
Hemophagocytic Lymphohistiocytosis Induced by Severe Pandemic Influenza A (H1N1) 2009 Virus Infection: A Case Report.2009年甲型H1N1大流行性流感病毒感染诱发噬血细胞性淋巴组织细胞增生症：一例报告
Case Rep Med. 2011;2011:951910. doi: 10.1155/2011/951910. Epub 2011 Apr 14.
7
Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.临床实践中治疗性血液成分单采的使用指南——来自美国血液成分单采协会血液成分单采应用委员会的循证方法
J Clin Apher. 2010;25(3):83-177. doi: 10.1002/jca.20240.
8
Atypical hemolytic-uremic syndrome.非典型溶血尿毒综合征
N Engl J Med. 2009 Oct 22;361(17):1676-87. doi: 10.1056/NEJMra0902814.
9
Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.移植相关性血栓性微血管病：移植物抗宿主病对治疗性血浆置换疗效的影响。
Bone Marrow Transplant. 2010 Apr;45(4):699-704. doi: 10.1038/bmt.2009.233. Epub 2009 Sep 21.
10
Thrombomodulin mutations in atypical hemolytic-uremic syndrome.非典型溶血性尿毒症综合征中的血栓调节蛋白突变
N Engl J Med. 2009 Jul 23;361(4):345-57. doi: 10.1056/NEJMoa0810739.
Zotero 插件